{"count":221304,"next":"https://panelapp-aus.org/api/v1/activities/?format=json&page=1703","previous":"https://panelapp-aus.org/api/v1/activities/?format=json&page=1701","results":[{"created":"2020-07-29T20:43:59.635963+10:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.3568","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: MYOZ2 as ready","entity_name":"MYOZ2","entity_type":"gene"},{"created":"2020-07-29T20:43:59.627781+10:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.3568","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: myoz2 has been classified as Red List (Low Evidence).","entity_name":"MYOZ2","entity_type":"gene"},{"created":"2020-07-29T20:43:52.524447+10:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.3568","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: MYOZ2 were changed from  to Cardiomyopathy, hypertrophic, 16 MIM#613838","entity_name":"MYOZ2","entity_type":"gene"},{"created":"2020-07-29T20:43:32.383216+10:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.3567","user_name":"Zornitza Stark","item_type":"entity","text":"Publications for gene: MYOZ2 were set to ","entity_name":"MYOZ2","entity_type":"gene"},{"created":"2020-07-29T20:43:04.627619+10:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.3566","user_name":"Zornitza Stark","item_type":"entity","text":"Mode of inheritance for gene: MYOZ2 was changed from Unknown to MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted","entity_name":"MYOZ2","entity_type":"gene"},{"created":"2020-07-29T20:42:36.265189+10:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.3565","user_name":"Zornitza Stark","item_type":"entity","text":"Classified gene: MYOZ2 as Red List (low evidence)","entity_name":"MYOZ2","entity_type":"gene"},{"created":"2020-07-29T20:42:36.256850+10:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.3565","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: myoz2 has been classified as Red List (Low Evidence).","entity_name":"MYOZ2","entity_type":"gene"},{"created":"2020-07-29T20:41:33.517250+10:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.3564","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: TRIM63 as ready","entity_name":"TRIM63","entity_type":"gene"},{"created":"2020-07-29T20:41:33.511605+10:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.3564","user_name":"Zornitza Stark","item_type":"entity","text":"Added comment: Comment when marking as ready: Large case series published subsequent to ClinGen assessment.","entity_name":"TRIM63","entity_type":"gene"},{"created":"2020-07-29T20:41:33.451374+10:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.3564","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: trim63 has been classified as Green List (High Evidence).","entity_name":"TRIM63","entity_type":"gene"},{"created":"2020-07-29T20:39:03.523455+10:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.3564","user_name":"Zornitza Stark","item_type":"entity","text":"Classified gene: TRIM63 as Green List (high evidence)","entity_name":"TRIM63","entity_type":"gene"},{"created":"2020-07-29T20:39:03.513142+10:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.3564","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: trim63 has been classified as Green List (High Evidence).","entity_name":"TRIM63","entity_type":"gene"},{"created":"2020-07-29T20:38:33.272877+10:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.3563","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: PDLIM3 as ready","entity_name":"PDLIM3","entity_type":"gene"},{"created":"2020-07-29T20:38:33.264138+10:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.3563","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: pdlim3 has been classified as Red List (Low Evidence).","entity_name":"PDLIM3","entity_type":"gene"},{"created":"2020-07-29T20:38:22.392042+10:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.3563","user_name":"Zornitza Stark","item_type":"entity","text":"Classified gene: PDLIM3 as Red List (low evidence)","entity_name":"PDLIM3","entity_type":"gene"},{"created":"2020-07-29T20:38:22.382091+10:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.3563","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: pdlim3 has been classified as Red List (Low Evidence).","entity_name":"PDLIM3","entity_type":"gene"},{"created":"2020-07-29T20:38:06.352857+10:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.3562","user_name":"Zornitza Stark","item_type":"entity","text":"Tag SV/CNV tag was added to gene: PDLIM3.","entity_name":"PDLIM3","entity_type":"gene"},{"created":"2020-07-29T20:37:23.881404+10:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.3562","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: OBSCN as ready","entity_name":"OBSCN","entity_type":"gene"},{"created":"2020-07-29T20:37:23.871484+10:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.3562","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: obscn has been classified as Red List (Low Evidence).","entity_name":"OBSCN","entity_type":"gene"},{"created":"2020-07-29T20:37:14.091649+10:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.3562","user_name":"Zornitza Stark","item_type":"entity","text":"Classified gene: OBSCN as Red List (low evidence)","entity_name":"OBSCN","entity_type":"gene"},{"created":"2020-07-29T20:37:14.058064+10:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.3562","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: obscn has been classified as Red List (Low Evidence).","entity_name":"OBSCN","entity_type":"gene"},{"created":"2020-07-29T20:36:10.211143+10:00","panel_name":"Cardiomyopathy_Paediatric","panel_id":3270,"panel_version":"0.0","user_name":"Zornitza Stark","item_type":"entity","text":"reviewed gene: SLC25A4: Rating: GREEN; Mode of pathogenicity: None; Publications: ; Phenotypes: Mitochondrial DNA depletion syndrome 12A (cardiomyopathic type) AD MIM#617184, Mitochondrial DNA depletion syndrome 12B (cardiomyopathic type) AR MIM#615418, Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant 2 MIM#609283; Mode of inheritance: BOTH monoallelic and biallelic, autosomal or pseudoautosomal","entity_name":"SLC25A4","entity_type":"gene"},{"created":"2020-07-29T20:35:37.609929+10:00","panel_name":"Cardiomyopathy_Paediatric","panel_id":3270,"panel_version":"0.0","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: SLC25A4 as ready","entity_name":"SLC25A4","entity_type":"gene"},{"created":"2020-07-29T20:35:37.600082+10:00","panel_name":"Cardiomyopathy_Paediatric","panel_id":3270,"panel_version":"0.0","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: slc25a4 has been classified as Green List (High Evidence).","entity_name":"SLC25A4","entity_type":"gene"},{"created":"2020-07-29T20:34:55.149927+10:00","panel_name":"Optic Atrophy","panel_id":149,"panel_version":"0.111","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: AFG3L2 were changed from Spastic ataxia 5, autosomal recessive (MIM#614487); Spinocerebellar ataxia 28 (MIM#610246) to Autosomal dominant optic atrophy; Spastic ataxia 5, autosomal recessive (MIM#614487); Spinocerebellar ataxia 28 (MIM#610246)","entity_name":"AFG3L2","entity_type":"gene"},{"created":"2020-07-29T20:34:14.427506+10:00","panel_name":"Optic Atrophy","panel_id":149,"panel_version":"0.110","user_name":"Zornitza Stark","item_type":"entity","text":"Publications for gene: AFG3L2 were set to 29181157; 26539208; 30252181; 30389403","entity_name":"AFG3L2","entity_type":"gene"},{"created":"2020-07-29T20:33:34.819052+10:00","panel_name":"Optic Atrophy","panel_id":149,"panel_version":"0.109","user_name":"Zornitza Stark","item_type":"entity","text":"Mode of inheritance for gene: AFG3L2 was changed from MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted to BOTH monoallelic and biallelic, autosomal or pseudoautosomal","entity_name":"AFG3L2","entity_type":"gene"},{"created":"2020-07-29T17:40:31.776675+10:00","panel_name":"Optic Atrophy","panel_id":149,"panel_version":"0.108","user_name":"Chern Lim","item_type":"entity","text":"reviewed gene: AFG3L2: Rating: GREEN; Mode of pathogenicity: None; Publications: 32219868, 32600459, 32548275; Phenotypes: Autosomal dominant optic atrophy, Autosomal recessive spastic ataxia 5, MIM#614487, Autosomal dominant spinocerebellar ataxia 28, MIM#610246; Mode of inheritance: BOTH monoallelic and biallelic, autosomal or pseudoautosomal; Current diagnostic: yes","entity_name":"AFG3L2","entity_type":"gene"},{"created":"2020-07-29T17:38:39.575502+10:00","panel_name":"Optic Atrophy","panel_id":149,"panel_version":"0.108","user_name":"Chern Lim","item_type":"entity","text":"Deleted their review","entity_name":"AFG3L2","entity_type":"gene"},{"created":"2020-07-29T17:37:17.096429+10:00","panel_name":"Optic Atrophy","panel_id":149,"panel_version":"0.108","user_name":"Chern Lim","item_type":"entity","text":"reviewed gene: AFG3L2: Rating: GREEN; Mode of pathogenicity: None; Publications: 32219868, 32600459, 32548275; Phenotypes: Optic atrophy; Mode of inheritance: MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted; Current diagnostic: yes","entity_name":"AFG3L2","entity_type":"gene"},{"created":"2020-07-29T17:04:44.619203+10:00","panel_name":"Hypertrophic cardiomyopathy_HCM","panel_id":111,"panel_version":"0.146","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: MYH6 as ready","entity_name":"MYH6","entity_type":"gene"},{"created":"2020-07-29T17:04:44.607879+10:00","panel_name":"Hypertrophic cardiomyopathy_HCM","panel_id":111,"panel_version":"0.146","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: myh6 has been classified as Red List (Low Evidence).","entity_name":"MYH6","entity_type":"gene"},{"created":"2020-07-29T17:04:41.745680+10:00","panel_name":"Hypertrophic cardiomyopathy_HCM","panel_id":111,"panel_version":"0.146","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: MYH6 were changed from  to Hypertrophic cardiomyopathy","entity_name":"MYH6","entity_type":"gene"},{"created":"2020-07-29T17:04:16.144181+10:00","panel_name":"Hypertrophic cardiomyopathy_HCM","panel_id":111,"panel_version":"0.145","user_name":"Zornitza Stark","item_type":"entity","text":"Publications for gene: MYH6 were set to ","entity_name":"MYH6","entity_type":"gene"},{"created":"2020-07-29T17:03:49.985454+10:00","panel_name":"Hypertrophic cardiomyopathy_HCM","panel_id":111,"panel_version":"0.144","user_name":"Zornitza Stark","item_type":"entity","text":"Mode of inheritance for gene: MYH6 was changed from Unknown to MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted","entity_name":"MYH6","entity_type":"gene"},{"created":"2020-07-29T17:03:25.691855+10:00","panel_name":"Hypertrophic cardiomyopathy_HCM","panel_id":111,"panel_version":"0.143","user_name":"Zornitza Stark","item_type":"entity","text":"Classified gene: MYH6 as Red List (low evidence)","entity_name":"MYH6","entity_type":"gene"},{"created":"2020-07-29T17:03:25.677649+10:00","panel_name":"Hypertrophic cardiomyopathy_HCM","panel_id":111,"panel_version":"0.143","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: myh6 has been classified as Red List (Low Evidence).","entity_name":"MYH6","entity_type":"gene"},{"created":"2020-07-29T17:02:29.618704+10:00","panel_name":"Hypertrophic cardiomyopathy_HCM","panel_id":111,"panel_version":"0.142","user_name":"Seb Lunke","item_type":"entity","text":"Marked gene: PLN as ready","entity_name":"PLN","entity_type":"gene"},{"created":"2020-07-29T17:02:29.578975+10:00","panel_name":"Hypertrophic cardiomyopathy_HCM","panel_id":111,"panel_version":"0.142","user_name":"Seb Lunke","item_type":"entity","text":"Gene: pln has been classified as Green List (High Evidence).","entity_name":"PLN","entity_type":"gene"},{"created":"2020-07-29T17:01:41.232944+10:00","panel_name":"Hypertrophic cardiomyopathy_HCM","panel_id":111,"panel_version":"0.142","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: PRKAG2 as ready","entity_name":"PRKAG2","entity_type":"gene"},{"created":"2020-07-29T17:01:41.224172+10:00","panel_name":"Hypertrophic cardiomyopathy_HCM","panel_id":111,"panel_version":"0.142","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: prkag2 has been classified as Green List (High Evidence).","entity_name":"PRKAG2","entity_type":"gene"},{"created":"2020-07-29T17:01:36.601961+10:00","panel_name":"Hypertrophic cardiomyopathy_HCM","panel_id":111,"panel_version":"0.142","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: PRKAG2 were changed from Cardiomyopathy, hypertrophic 6, MIM# 600858 to Cardiomyopathy, hypertrophic 6, MIM# 600858","entity_name":"PRKAG2","entity_type":"gene"},{"created":"2020-07-29T17:01:22.285467+10:00","panel_name":"Hypertrophic cardiomyopathy_HCM","panel_id":111,"panel_version":"0.142","user_name":"Seb Lunke","item_type":"entity","text":"Phenotypes for gene: PLN were changed from  to Cardiomyopathy, hypertrophic, 18\t(MIM #613874)","entity_name":"PLN","entity_type":"gene"},{"created":"2020-07-29T17:00:28.793610+10:00","panel_name":"Hypertrophic cardiomyopathy_HCM","panel_id":111,"panel_version":"0.141","user_name":"Seb Lunke","item_type":"entity","text":"Publications for gene: PLN were set to ","entity_name":"PLN","entity_type":"gene"},{"created":"2020-07-29T17:00:14.927582+10:00","panel_name":"Hypertrophic cardiomyopathy_HCM","panel_id":111,"panel_version":"0.141","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: PRKAG2 were changed from  to Cardiomyopathy, hypertrophic 6, MIM# 600858","entity_name":"PRKAG2","entity_type":"gene"},{"created":"2020-07-29T16:59:46.688097+10:00","panel_name":"Hypertrophic cardiomyopathy_HCM","panel_id":111,"panel_version":"0.140","user_name":"Zornitza Stark","item_type":"entity","text":"Publications for gene: PRKAG2 were set to ","entity_name":"PRKAG2","entity_type":"gene"},{"created":"2020-07-29T16:59:19.566323+10:00","panel_name":"Hypertrophic cardiomyopathy_HCM","panel_id":111,"panel_version":"0.139","user_name":"Zornitza Stark","item_type":"entity","text":"Mode of inheritance for gene: PRKAG2 was changed from Unknown to MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted","entity_name":"PRKAG2","entity_type":"gene"},{"created":"2020-07-29T16:58:53.714976+10:00","panel_name":"Hypertrophic cardiomyopathy_HCM","panel_id":111,"panel_version":"0.138","user_name":"Zornitza Stark","item_type":"entity","text":"reviewed gene: PRKAG2: Rating: GREEN; Mode of pathogenicity: None; Publications: ; Phenotypes: Cardiomyopathy, hypertrophic 6, MIM# 600858; Mode of inheritance: MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted","entity_name":"PRKAG2","entity_type":"gene"},{"created":"2020-07-29T16:58:45.530466+10:00","panel_name":"Hypertrophic cardiomyopathy_HCM","panel_id":111,"panel_version":"0.138","user_name":"Seb Lunke","item_type":"entity","text":"Mode of inheritance for gene: PLN was changed from Unknown to MONOALLELIC, autosomal or pseudoautosomal, imprinted status unknown","entity_name":"PLN","entity_type":"gene"},{"created":"2020-07-29T16:55:21.762256+10:00","panel_name":"Hypertrophic cardiomyopathy_HCM","panel_id":111,"panel_version":"0.137","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: LAMP2 as ready","entity_name":"LAMP2","entity_type":"gene"},{"created":"2020-07-29T16:55:21.751185+10:00","panel_name":"Hypertrophic cardiomyopathy_HCM","panel_id":111,"panel_version":"0.137","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: lamp2 has been classified as Green List (High Evidence).","entity_name":"LAMP2","entity_type":"gene"},{"created":"2020-07-29T16:55:19.546035+10:00","panel_name":"Hypertrophic cardiomyopathy_HCM","panel_id":111,"panel_version":"0.137","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: LAMP2 were changed from  to Danon disease (MIM#300257)","entity_name":"LAMP2","entity_type":"gene"},{"created":"2020-07-29T16:54:55.817488+10:00","panel_name":"Hypertrophic cardiomyopathy_HCM","panel_id":111,"panel_version":"0.136","user_name":"Zornitza Stark","item_type":"entity","text":"Publications for gene: LAMP2 were set to ","entity_name":"LAMP2","entity_type":"gene"},{"created":"2020-07-29T16:54:32.526988+10:00","panel_name":"Hypertrophic cardiomyopathy_HCM","panel_id":111,"panel_version":"0.135","user_name":"Zornitza Stark","item_type":"entity","text":"Mode of inheritance for gene: LAMP2 was changed from Unknown to X-LINKED: hemizygous mutation in males, monoallelic mutations in females may cause disease (may be less severe, later onset than males)","entity_name":"LAMP2","entity_type":"gene"},{"created":"2020-07-29T16:53:54.766006+10:00","panel_name":"Hypertrophic cardiomyopathy_HCM","panel_id":111,"panel_version":"0.134","user_name":"Zornitza Stark","item_type":"entity","text":"reviewed gene: LAMP2: Rating: GREEN; Mode of pathogenicity: None; Publications: ; Phenotypes: Danon disease (MIM#300257); Mode of inheritance: None","entity_name":"LAMP2","entity_type":"gene"},{"created":"2020-07-29T16:53:51.803583+10:00","panel_name":"Hypertrophic cardiomyopathy_HCM","panel_id":111,"panel_version":"0.134","user_name":"Seb Lunke","item_type":"entity","text":"Marked gene: TTR as ready","entity_name":"TTR","entity_type":"gene"},{"created":"2020-07-29T16:53:51.799780+10:00","panel_name":"Hypertrophic cardiomyopathy_HCM","panel_id":111,"panel_version":"0.134","user_name":"Seb Lunke","item_type":"entity","text":"Added comment: Comment when marking as ready: Can present predominantly with HCM","entity_name":"TTR","entity_type":"gene"},{"created":"2020-07-29T16:53:51.772266+10:00","panel_name":"Hypertrophic cardiomyopathy_HCM","panel_id":111,"panel_version":"0.134","user_name":"Seb Lunke","item_type":"entity","text":"Gene: ttr has been classified as Green List (High Evidence).","entity_name":"TTR","entity_type":"gene"},{"created":"2020-07-29T16:53:28.245142+10:00","panel_name":"Hypertrophic cardiomyopathy_HCM","panel_id":111,"panel_version":"0.134","user_name":"Seb Lunke","item_type":"entity","text":"Phenotypes for gene: TTR were changed from  to Amyloidosis, hereditary, transthyretin-related MIM#105210","entity_name":"TTR","entity_type":"gene"},{"created":"2020-07-29T16:53:02.818780+10:00","panel_name":"Hypertrophic cardiomyopathy_HCM","panel_id":111,"panel_version":"0.133","user_name":"Seb Lunke","item_type":"entity","text":"Publications for gene: TTR were set to ","entity_name":"TTR","entity_type":"gene"},{"created":"2020-07-29T16:52:43.652158+10:00","panel_name":"Hypertrophic cardiomyopathy_HCM","panel_id":111,"panel_version":"0.132","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: GLA were changed from Fabry disease (MIM# 301500) to Fabry disease (MIM# 301500)","entity_name":"GLA","entity_type":"gene"},{"created":"2020-07-29T16:52:26.491809+10:00","panel_name":"Hypertrophic cardiomyopathy_HCM","panel_id":111,"panel_version":"0.131","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: GLA as ready","entity_name":"GLA","entity_type":"gene"},{"created":"2020-07-29T16:52:26.483688+10:00","panel_name":"Hypertrophic cardiomyopathy_HCM","panel_id":111,"panel_version":"0.131","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: gla has been classified as Green List (High Evidence).","entity_name":"GLA","entity_type":"gene"},{"created":"2020-07-29T16:52:24.548970+10:00","panel_name":"Hypertrophic cardiomyopathy_HCM","panel_id":111,"panel_version":"0.131","user_name":"Seb Lunke","item_type":"entity","text":"Mode of inheritance for gene: TTR was changed from Unknown to MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted","entity_name":"TTR","entity_type":"gene"},{"created":"2020-07-29T16:52:06.699748+10:00","panel_name":"Hypertrophic cardiomyopathy_HCM","panel_id":111,"panel_version":"0.131","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: GLA were changed from  to Fabry disease (MIM# 301500)","entity_name":"GLA","entity_type":"gene"},{"created":"2020-07-29T16:51:37.357477+10:00","panel_name":"Hypertrophic cardiomyopathy_HCM","panel_id":111,"panel_version":"0.130","user_name":"Zornitza Stark","item_type":"entity","text":"Publications for gene: GLA were set to ","entity_name":"GLA","entity_type":"gene"},{"created":"2020-07-29T16:51:19.990031+10:00","panel_name":"Hypertrophic cardiomyopathy_HCM","panel_id":111,"panel_version":"0.130","user_name":"Zornitza Stark","item_type":"entity","text":"Mode of inheritance for gene: GLA was changed from X-LINKED: hemizygous mutation in males, monoallelic mutations in females may cause disease (may be less severe, later onset than males) to X-LINKED: hemizygous mutation in males, monoallelic mutations in females may cause disease (may be less severe, later onset than males)","entity_name":"GLA","entity_type":"gene"},{"created":"2020-07-29T16:51:04.660265+10:00","panel_name":"Hypertrophic cardiomyopathy_HCM","panel_id":111,"panel_version":"0.129","user_name":"Zornitza Stark","item_type":"entity","text":"Mode of inheritance for gene: GLA was changed from Unknown to X-LINKED: hemizygous mutation in males, monoallelic mutations in females may cause disease (may be less severe, later onset than males)","entity_name":"GLA","entity_type":"gene"},{"created":"2020-07-29T16:50:30.948194+10:00","panel_name":"Hypertrophic cardiomyopathy_HCM","panel_id":111,"panel_version":"0.128","user_name":"Zornitza Stark","item_type":"entity","text":"reviewed gene: GLA: Rating: GREEN; Mode of pathogenicity: None; Publications: ; Phenotypes: Fabry disease (MIM# 301500); Mode of inheritance: X-LINKED: hemizygous mutation in males, monoallelic mutations in females may cause disease (may be less severe, later onset than males)","entity_name":"GLA","entity_type":"gene"},{"created":"2020-07-29T16:50:07.626502+10:00","panel_name":"Hypertrophic cardiomyopathy_HCM","panel_id":111,"panel_version":"0.128","user_name":"Seb Lunke","item_type":"entity","text":"Marked gene: GAA as ready","entity_name":"GAA","entity_type":"gene"},{"created":"2020-07-29T16:50:07.615973+10:00","panel_name":"Hypertrophic cardiomyopathy_HCM","panel_id":111,"panel_version":"0.128","user_name":"Seb Lunke","item_type":"entity","text":"Gene: gaa has been classified as Red List (Low Evidence).","entity_name":"GAA","entity_type":"gene"},{"created":"2020-07-29T16:49:43.564712+10:00","panel_name":"Hypertrophic cardiomyopathy_HCM","panel_id":111,"panel_version":"0.128","user_name":"Seb Lunke","item_type":"entity","text":"Classified gene: GAA as Red List (low evidence)","entity_name":"GAA","entity_type":"gene"},{"created":"2020-07-29T16:49:43.554243+10:00","panel_name":"Hypertrophic cardiomyopathy_HCM","panel_id":111,"panel_version":"0.128","user_name":"Seb Lunke","item_type":"entity","text":"Gene: gaa has been classified as Red List (Low Evidence).","entity_name":"GAA","entity_type":"gene"},{"created":"2020-07-29T16:49:26.648271+10:00","panel_name":"Hypertrophic cardiomyopathy_HCM","panel_id":111,"panel_version":"0.127","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: FXN as ready","entity_name":"FXN","entity_type":"gene"},{"created":"2020-07-29T16:49:26.633098+10:00","panel_name":"Hypertrophic cardiomyopathy_HCM","panel_id":111,"panel_version":"0.127","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: fxn has been classified as Red List (Low Evidence).","entity_name":"FXN","entity_type":"gene"},{"created":"2020-07-29T16:49:24.185691+10:00","panel_name":"Hypertrophic cardiomyopathy_HCM","panel_id":111,"panel_version":"0.127","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: FXN were changed from  to Friedreich ataxia MIM#229300","entity_name":"FXN","entity_type":"gene"},{"created":"2020-07-29T16:49:00.832110+10:00","panel_name":"Hypertrophic cardiomyopathy_HCM","panel_id":111,"panel_version":"0.126","user_name":"Zornitza Stark","item_type":"entity","text":"Mode of inheritance for gene: FXN was changed from Unknown to BIALLELIC, autosomal or pseudoautosomal","entity_name":"FXN","entity_type":"gene"},{"created":"2020-07-29T16:48:46.539102+10:00","panel_name":"Cardiomyopathy_Paediatric","panel_id":3270,"panel_version":"0.0","user_name":"Paul De Fazio","item_type":"entity","text":"reviewed gene: SLC25A4: Rating: RED; Mode of pathogenicity: None; Publications: 16155110; Phenotypes: Mitochondrial DNA depletion syndrome 12A (cardiomyopathic type) AD MIM#617184, Mitochondrial DNA depletion syndrome 12B (cardiomyopathic type) AR MIM#615418, Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant 2 MIM#609283; Mode of inheritance: BOTH monoallelic and biallelic, autosomal or pseudoautosomal; Current diagnostic: yes","entity_name":"SLC25A4","entity_type":"gene"},{"created":"2020-07-29T16:48:44.496238+10:00","panel_name":"Hypertrophic cardiomyopathy_HCM","panel_id":111,"panel_version":"0.125","user_name":"Zornitza Stark","item_type":"entity","text":"Classified gene: FXN as Red List (low evidence)","entity_name":"FXN","entity_type":"gene"},{"created":"2020-07-29T16:48:44.484700+10:00","panel_name":"Hypertrophic cardiomyopathy_HCM","panel_id":111,"panel_version":"0.125","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: fxn has been classified as Red List (Low Evidence).","entity_name":"FXN","entity_type":"gene"},{"created":"2020-07-29T16:47:56.671483+10:00","panel_name":"Hypertrophic cardiomyopathy_HCM","panel_id":111,"panel_version":"0.124","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: SLC25A4 as ready","entity_name":"SLC25A4","entity_type":"gene"},{"created":"2020-07-29T16:47:56.662384+10:00","panel_name":"Hypertrophic cardiomyopathy_HCM","panel_id":111,"panel_version":"0.124","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: slc25a4 has been classified as Red List (Low Evidence).","entity_name":"SLC25A4","entity_type":"gene"},{"created":"2020-07-29T16:47:52.332243+10:00","panel_name":"Hypertrophic cardiomyopathy_HCM","panel_id":111,"panel_version":"0.124","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: SLC25A4 were changed from Mitochondrial DNA depletion syndrome 12A (cardiomyopathic type) AD MIM#617184; Mitochondrial DNA depletion syndrome 12B (cardiomyopathic type) AR MIM#615418; Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant 2 MIM#609283 to Mitochondrial DNA depletion syndrome 12A (cardiomyopathic type) AD MIM#617184; Mitochondrial DNA depletion syndrome 12B (cardiomyopathic type) AR MIM#615418; Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant 2 MIM#609283","entity_name":"SLC25A4","entity_type":"gene"},{"created":"2020-07-29T16:47:34.426086+10:00","panel_name":"Hypertrophic cardiomyopathy_HCM","panel_id":111,"panel_version":"0.124","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: SLC25A4 were changed from  to Mitochondrial DNA depletion syndrome 12A (cardiomyopathic type) AD MIM#617184; Mitochondrial DNA depletion syndrome 12B (cardiomyopathic type) AR MIM#615418; Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant 2 MIM#609283","entity_name":"SLC25A4","entity_type":"gene"},{"created":"2020-07-29T16:47:13.754450+10:00","panel_name":"Hypertrophic cardiomyopathy_HCM","panel_id":111,"panel_version":"0.123","user_name":"Zornitza Stark","item_type":"entity","text":"Publications for gene: SLC25A4 were set to ","entity_name":"SLC25A4","entity_type":"gene"},{"created":"2020-07-29T16:46:46.631765+10:00","panel_name":"Hypertrophic cardiomyopathy_HCM","panel_id":111,"panel_version":"0.122","user_name":"Zornitza Stark","item_type":"entity","text":"Mode of inheritance for gene: SLC25A4 was changed from Unknown to BOTH monoallelic and biallelic, autosomal or pseudoautosomal","entity_name":"SLC25A4","entity_type":"gene"},{"created":"2020-07-29T16:46:42.457488+10:00","panel_name":"Hypertrophic cardiomyopathy_HCM","panel_id":111,"panel_version":"0.121","user_name":"Seb Lunke","item_type":"entity","text":"Marked gene: MT-TI as ready","entity_name":"MT-TI","entity_type":"gene"},{"created":"2020-07-29T16:46:42.452642+10:00","panel_name":"Hypertrophic cardiomyopathy_HCM","panel_id":111,"panel_version":"0.121","user_name":"Seb Lunke","item_type":"entity","text":"Added comment: Comment when marking as ready: NOTE: Mitochondrial DNA gene not tractable by many commonly used genomics methods.","entity_name":"MT-TI","entity_type":"gene"},{"created":"2020-07-29T16:46:42.408619+10:00","panel_name":"Hypertrophic cardiomyopathy_HCM","panel_id":111,"panel_version":"0.121","user_name":"Seb Lunke","item_type":"entity","text":"Gene: mt-ti has been classified as Green List (High Evidence).","entity_name":"MT-TI","entity_type":"gene"},{"created":"2020-07-29T16:46:29.938879+10:00","panel_name":"Hypertrophic cardiomyopathy_HCM","panel_id":111,"panel_version":"0.121","user_name":"Zornitza Stark","item_type":"entity","text":"Classified gene: SLC25A4 as Red List (low evidence)","entity_name":"SLC25A4","entity_type":"gene"},{"created":"2020-07-29T16:46:29.930882+10:00","panel_name":"Hypertrophic cardiomyopathy_HCM","panel_id":111,"panel_version":"0.121","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: slc25a4 has been classified as Red List (Low Evidence).","entity_name":"SLC25A4","entity_type":"gene"},{"created":"2020-07-29T16:45:50.016495+10:00","panel_name":"Hypertrophic cardiomyopathy_HCM","panel_id":111,"panel_version":"0.120","user_name":"Seb Lunke","item_type":"entity","text":"Classified gene: MT-TI as Green List (high evidence)","entity_name":"MT-TI","entity_type":"gene"},{"created":"2020-07-29T16:45:50.005751+10:00","panel_name":"Hypertrophic cardiomyopathy_HCM","panel_id":111,"panel_version":"0.120","user_name":"Seb Lunke","item_type":"entity","text":"Gene: mt-ti has been classified as Green List (High Evidence).","entity_name":"MT-TI","entity_type":"gene"},{"created":"2020-07-29T16:44:12.839489+10:00","panel_name":"Hypertrophic cardiomyopathy_HCM","panel_id":111,"panel_version":"0.119","user_name":"Seb Lunke","item_type":"entity","text":"Tag mtDNA tag was added to gene: MT-TI.","entity_name":"MT-TI","entity_type":"gene"},{"created":"2020-07-29T16:37:34.073894+10:00","panel_name":"Hypertrophic cardiomyopathy_HCM","panel_id":111,"panel_version":"0.119","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: TTN as ready","entity_name":"TTN","entity_type":"gene"},{"created":"2020-07-29T16:37:34.063959+10:00","panel_name":"Hypertrophic cardiomyopathy_HCM","panel_id":111,"panel_version":"0.119","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: ttn has been classified as Amber List (Moderate Evidence).","entity_name":"TTN","entity_type":"gene"},{"created":"2020-07-29T16:37:30.917004+10:00","panel_name":"Hypertrophic cardiomyopathy_HCM","panel_id":111,"panel_version":"0.119","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: TTN were changed from  to Hypertrophic cardiomyopathy","entity_name":"TTN","entity_type":"gene"},{"created":"2020-07-29T16:37:14.576273+10:00","panel_name":"Hypertrophic cardiomyopathy_HCM","panel_id":111,"panel_version":"0.118","user_name":"Zornitza Stark","item_type":"entity","text":"Publications for gene: TTN were set to ","entity_name":"TTN","entity_type":"gene"},{"created":"2020-07-29T16:36:51.857832+10:00","panel_name":"Hypertrophic cardiomyopathy_HCM","panel_id":111,"panel_version":"0.117","user_name":"Zornitza Stark","item_type":"entity","text":"Classified gene: TTN as Amber List (moderate evidence)","entity_name":"TTN","entity_type":"gene"},{"created":"2020-07-29T16:36:51.845289+10:00","panel_name":"Hypertrophic cardiomyopathy_HCM","panel_id":111,"panel_version":"0.117","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: ttn has been classified as Amber List (Moderate Evidence).","entity_name":"TTN","entity_type":"gene"}]}